The Elon Musk Era, Neuralink Loading
Quote from Ndubuisi Ekekwe on May 26, 2023, 7:13 PMPeople, one man runs this world. This generation is sharing the planet with Elon Musk. He is super-amazing. Neuralink has been approved by the FDA for trials on humans.
https://twitter.com/neuralink/status/1661857379460468736
Neuralink — Elon Musk’s brain-implant company — said on Twitter that it has received approval from the U.S. Food and Drug Administration (FDA) to conduct human trials. The company has been building a device than can be surgically inserted into the brain to sync up with computers, potentially treating conditions such as paralysis and blindness. Previous trials had only been done on animals, and an earlier bid by Neuralink to win FDA approval was rejected on safety grounds, per Reuters. The FDA has yet to comment, but experts have warned the brain implants would require extensive testing to overcome "technical and ethical challenges." (LinkedIn News)
People, one man runs this world. This generation is sharing the planet with Elon Musk. He is super-amazing. Neuralink has been approved by the FDA for trials on humans.
We are excited to share that we have received the FDA’s approval to launch our first-in-human clinical study!
This is the result of incredible work by the Neuralink team in close collaboration with the FDA and represents an important first step that will one day allow our…
— Neuralink (@neuralink) May 25, 2023
Neuralink — Elon Musk’s brain-implant company — said on Twitter that it has received approval from the U.S. Food and Drug Administration (FDA) to conduct human trials. The company has been building a device than can be surgically inserted into the brain to sync up with computers, potentially treating conditions such as paralysis and blindness. Previous trials had only been done on animals, and an earlier bid by Neuralink to win FDA approval was rejected on safety grounds, per Reuters. The FDA has yet to comment, but experts have warned the brain implants would require extensive testing to overcome "technical and ethical challenges." (LinkedIn News)